Drivers of Rising Health Care Costs And their Impact on Vulnerable Populations

whitePaper | May 15, 2022

The zero trust security framework is predicated on the foundational concept that implicit trust of users and devices in the environment increases the risk of a potential compromise. By eliminating this implicit trust and requiring strict identification and authentication throughout the network

whitePaper | February 15, 2022

Every provider wants to innovate to drive transformation that helps reduce variability, improve efficiency, and support optimal patient care. The question is, how disruptive, in a positive sense, is your innovation? Most innovations in provider organizations are, in truth, iterative tweaks. While tweaks are the cornerstone of continuous improvement lifecycles, iteration isn’t the kind of transformation needed in healthcare. Real innovation creates a disruptive solution that fundamentally changes how people and processes work together, for the better.

whitePaper | May 17, 2022

Like many other parts of life, the healthcare journey has radically transformed over the last two years. An increasing number of patients and doctors are taking advantage of digital channels for consultations, treatments, and ongoing medical care.

whitePaper | June 7, 2022

Today’s consumers expect personalized, convenient experiences. Several industries have adopted technologies to provide a seamless experience for their customers across multiple platforms.

whitePaper | February 6, 2020

Improving telehealth success with Healthcare specific devices. One of the primary challenges faced by clinicians with telehealth appointments is effectively and efficiently bringing both parties together without any breakdown in communication. Therefore, it's imperative that the hardware being utilized can support excellent audio with noise cancelling features, hi-res video and integrated hi-def cameras - without these items’ physicians are left with a good idea of the issue at hand but no way to implement.

whitePaper | January 27, 2023

Big Pharma conducted most of its early-stage clinical studies in the West before incorporating Asian locations in later phase studies. Though the Asian region had limited experience in the beginning, over time, researchers’ and local regional experience.